CompletedPhase 2NCT05222152
Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency
Studying Addison disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Neurocrine UK Limited
- Principal Investigator
- R RossNeurocrine UK Limited
- Intervention
- Chronocort(drug)
- Enrollment
- 58 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2023
Study locations (7)
- Diurnal Investigational Site in Hamburg, Hamburg, Germany
- Diurnal Investigational Site in Munich, Munich, Germany
- Diurnal Investigational Site in Würzburg, Würzburg, Germany
- Diurnal Investigational Site in Birmingham, Birmingham, United Kingdom
- Diurnal Investigational Site in Cardiff, Cardiff, United Kingdom
- Diurnal Investigational Site in Newcastle, Newcastle, United Kingdom
- Diurnal Investigational Site in Sheffield, Sheffield, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05222152 on ClinicalTrials.govOther trials for Addison disease
Additional recruiting or active studies for the same condition.